Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Nystatin products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An antifungal used to treat yeast infections of the mouth, skin and digestive tract.
Products affected
1 / 8
In shortage since
Jun 3, 2026
Reports on file
58
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · since Jun 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP-NYSTATIN ORAL SUSPENSION USP
100000UNIT · SUSPENSION · JAMP PHARMA CORPORATION
DIN 02433443 · ended Aug 18, 2025 · Demand increase for the drug.
Resolved
JAMP-NYSTATIN ORAL SUSPENSION USP
100000UNIT · SUSPENSION · JAMP PHARMA CORPORATION
DIN 02433443 · ended Jul 14, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
Resolved
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · ended Oct 30, 2024 · Disruption of the manufacture of the drug.
Resolved
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · ended Oct 29, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.
Discontinued
NYADERM
25000UNIT · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716901
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Jun 18, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Jan 10, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Dec 13, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 58 reports. All reports are on file with Health Canada.
What's happening
Nystatin is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Nystatin is classified under “INTESTINALANTIINFECTIVES” (ATC A07AA).
Recent changes
No changes recorded yet.
Common questions
What is Nystatin used for?
An antifungal used to treat yeast infections of the mouth, skin and digestive tract.
When will Nystatin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Nystatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.